Skip to main content

Table 1 Baseline Characteristics

From: Early fluid management affects short-term mortality in patients with end-stage kidney disease undergoing chronic hemodialysis and requiring continuous renal replacement therapy

 

Overall (n = 110)

14-day survival

p-value

Survivor, n = 76

Non-survivor, n = 34

Demographics

  Age

67.9 ± 11.4

67.8 ± 11.1

68.2 ± 12.1

0.86

  Male, n (%)

71 (64.5)

50 (65.8)

21 (61.8)

0.68

  Body weight at admission (Kg)

60.9 ± 12.5

61.3 ± 11.8

59.8 ± 14.0

0.56

  BMI at admission (kg/m2)

60.9 ± 12.5

23.4 ± 4.2

22.5 ± 4.0

0.31

Comorbidities, n (%)

 Hypertension

79 (71.8)

58 (76.3)

21(61.8)

0.12

 Diabetes

61 (55.5)

47 (61.8)

14(41.2)

0.04

 CVDs

46 (41.8)

34 (44.7)

12(35.3)

0.35

 Malignancy

19 (17.3)

13 (17.1)

6(17.6)

0.94

Cause of hospitalization, n (%)

 Sepsis

83 (75.5)

55 (72.4)

28 (82.4)

0.26

 non-sepsis

27 (24.5)

21 (27.6)

6 (17.6)

 CCI

6.7 ± 2.2

6.9 ± 2.3

6.3 ± 1.9

0.20

 SOFA

11.3 ± 3.4

11.6 ± 3.6

10.6 ± 2.9

0.20

 GCS

8.0 ± 4.0

8.6 ± 3.8

6.4 ± 4.0

0.01

 APACHE II

22.4 ± 6.8

21.3 ± 6.6

24.7 ± 6.8

0.01

 Mechanical Ventilation, n (%)

35 (31.8)

24 (31.6)

11 (32.4)

0.94

  1. Data were presented as mean ± standard deviation or number (%). Abbreviation: BMI Body mass index, CVD Cardiovascular disease, CCI Charlson Comorbidity Index, SOFA, Sequential Organ Failure Assessment, GCS Glasgow Coma Scale, APCHE II Acute Physiology and Chronic Health Evaluation II